4//SEC Filing
Sial Jay 4
Accession 0001140361-21-024855
CIK 0000748592other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 9:30 PM ET
Size
8.1 KB
Accession
0001140361-21-024855
Insider Transaction Report
Form 4
Sial Jay
See Remarks
Transactions
- Award
Stock Option
2021-07-15+71,000→ 71,000 totalExercise: $10.31Exp: 2031-07-15→ Common Stock (71,000 underlying) - Award
Restricted Stock Unit
2021-07-15+35,700→ 35,700 totalExp: 2031-07-15→ Common Stock (35,700 underlying)
Footnotes (3)
- [F1]The option vests and becomes exercisable over four years, with twenty-five percent of the shares covered thereby vesting on July 15, 2022, and 1/36 of the remaining shares covered thereby vesting on the 15th day of each calendar month from August 2022 through July 15, 2025, subject to continued service through each vesting date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F3]The RSU Grant vests and becomes exercisable in four equal installments on July 15 of each of 2022, 2023, 2024 and 2025, provided that it shall vest in full immediately prior to a change in control (as defined in Mr. Sial's Executive Employment Agreement, dated as of July 6, 2021 and effective July 15, 2021), subject to continued service through each vesting date.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001873057
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 9:30 PM ET
- Size
- 8.1 KB